ArticleCancer diagnosis & prognosis
Possible Sarcopenia and Functional Decline After Colorectal or Gastric Cancer Surgery.
Article in Cancer diagnosis & prognosis. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/Aim: While possible sarcopenia may influence short-term outcomes following gastrointestinal cancer surgery, its relationship with physical function at discharge remains poorly characterized. This study investigated the association between preoperative possible sarcopenia and functional decline at discharge. Patients and Methods: This single-center retrospective cohort study included 200 consecutive patients who underwent elective colorectal or gastric cancer resection at Saitama Sekishinkai Hospital between January 2024 and August 2025. Possible sarcopenia was defined according to the Asian Working Group for Sarcopenia 2025 (AWGS 2025) criteria. Functional decline at discharge was defined as a decrease of ≥1 point in the Short Physical Performance Battery (SPPB) total score from the preoperative assessment to discharge. Modified Poisson regression was used to estimate relative risks (RRs) and 95% confidence intervals (CIs). Results: Of the 200 patients, 54 (27.0%) had possible sarcopenia and 37 (18.5%) showed functional decline at discharge. Functional decline occurred in 19 of 54 patients (35.2%) with possible sarcopenia and in 18 of 146 patients (12.3%) without possible sarcopenia. Possible sarcopenia was associated with functional decline in the crude model (RR=2.85, 95%CI=1.59-5.15; Conclusion: Preoperative possible sarcopenia was independently associated with functional decline at discharge after colorectal or gastric cancer resection. Handgrip strength assessment may be a practical preoperative screening tool for identifying patients at risk and for planning perioperative rehabilitation or prehabilitation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.